Anhedonia as a component of the tobacco withdrawal syndrome.
Animal research suggests that anhedonia is a tobacco withdrawal symptom, but this topic has not been addressed definitively in research with humans. This research sought to determine whether anhedonia is (a) an element of the tobacco withdrawal syndrome in humans and (b) an impediment to successful tobacco cessation. Data were from 1,175 smokers (58.3% women; 85.5% White) participating in a randomized double-blind, placebo-controlled trial of smoking cessation pharmacotherapies. Ecological momentary assessments for 5 days before and 10 days after the target quit day were used to assess anhedonia and other established withdrawal symptoms. Consistent with drug withdrawal, anhedonia showed an inverted-U pattern of change in response to tobacco cessation and was associated with the severity of other withdrawal symptoms and tobacco dependence. Postquit anhedonia was associated with decreased latency to relapse (hazard ratio = 1.09, 95% confidence interval [CI] [1.02, 1.17]) and with lower 8-week point-prevalence abstinence (odds ratio = .91, 95% CI [.86, .97])-relations that remained significant when other withdrawal symptoms were included as predictors. Finally, nicotine replacement therapy nearly fully suppressed the increase in abstinence-related anhedonia (β = -.66, p < .001), suggesting agonist suppression of withdrawal. Results suggest that anhedonia is a unique and motivationally significant element of the tobacco withdrawal syndrome in humans. These results have implications for defining and assessing tobacco use disorder and for understanding and treating tobacco addiction.
Center for Tobacco Research and Intervention.
Jessica W
JW
Cook
Center for Tobacco Research and Intervention.
Megan E
ME
Piper
Department of Preventive Medicine, Keck School of Medicine, University of Southern California.
Adam M
AM
Leventhal
Center for Tobacco Research and Intervention.
Tanya R
TR
Schlam
Center for Tobacco Research and Intervention.
Michael C
MC
Fiore
Center for Tobacco Research and Intervention.
Timothy B
TB
Baker
D000328:Adult; D059445:Anhedonia / Q000187:drug effects; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009538:Nicotine / Q000819:agonists; D018722:Nicotinic Agonists / Q000494:pharmacology; D012907:Smoking / Q000188:drug therapy; D016540:Smoking Cessation / Q000523:psychology*; D013375:Substance Withdrawal Syndrome / Q000523:psychology*
D018722:Nicotinic Agonists; D009538:Nicotine